Innovative Platform for Robust and Scalable Lentiviral Vector Purification

Tuesday, March 19, 2024 at 3:00 PM to 3:20 PM · 20 min. (Europe/London)
Viral Vector Manufacturing [Track 9]
Presentation
Astrea Bioseparations
51
Astrea Bioseparations is focused on bringing advanced therapies to market with industry leading bioseparation technologies. Our team has been supplying world class products for FDA and EMA approved manufacturing processes for over 30 years. Our proprietary agarose bead technology, PuraBead® , is manufactured to ISO 9001 accredited standards. Security of supply is ensured, with in-house manufacturing capabilities of up to 1000 L batch sizes. We support the biopharmaceutical industry with products and services that help bring life-improving and life-saving medicines to market. Regardless of process scale, we are ready to build Purity by Design into each process to ensure quality and speed to market.

Documents & Links

  • Innovative Platform for Robust and Scalable Lentiviral Vector Purification

Registered attendees

Auffret-Cariou Adrien
Auffret-Cariou Adrien
Process Development ProjectsSK pharmteco
Ben Weil
Ben Weil
Chief Operating Officer & Chief Manufacturing OfficerINmuneBio
Emmanuelle Cameau
Emmanuelle Cameau
Scientific Director Viral VectorsCytiva

Log in

See all the content and easy-to-use features by logging in or registering!